NRC Frequently Asked Questions
Last verified on November 16, 2020
Non-Authorized User Duties
If a radiologist is not an Authorized User (AU) on an NRC license at an institution, what duties may he or she perform in the nuclear radiology or nuclear medicine laboratory of that facility?
The NRC recognizes that it is frequently necessary for an Authorized User (AU) to delegate to other individuals the specific tasks associated with preparing and administering by-product material (radionuclides or radiopharmaceuticals) for medical use in patients (10 CFR 35.27). These individuals include technologists and other physicians who may not be AUs.
If the policies and procedures of the institution holding an NRC radioactive materials license allow, the NRC regulations permit delegation of these duties if the individuals performing the duties are properly instructed and supervised. Specifically, 10 CFR 35, Subpart D – Unsealed By-product Material – Written Directive Not Required:
- §35.100 – Use of unsealed by-product material for uptake, dilution, and excretion studies for which a written directive is not required
- §35.200 – Use of unsealed by-product material for imaging and localization studies for which a written directive is not required
Subpart E – Unsealed By-product Material – Written Directive Required:
- §35.300 – Use of unsealed by-product material for which a written directive is required
The supervising AU need not be physically present for delegated use of by-product material under sub-parts D
and E. Furthermore, there is no NRC requirement that diagnostic examinations performed using by-product material must be interpreted by an AU. Thus, the NRC regulations do not restrict who can interpret and report diagnostic imaging or the results of therapeutic procedures (i.e., radiologists who are not AUs may interpret and report such examinations and procedures). However, it is strongly recommended that those non-AU and AU radiologists practicing in NRC/ Agreement States consult the appropriate state regulatory agency to ensure that the state regulations allow for this delegation.
According to NRC regulations, only an AU can sign a written directive, including those necessary for therapeutic procedures involving unsealed by-product material (e.g., treatment of hyperthyroidism, ablation of residual functional thyroid tissue, or treatment of functioning thyroid metastases using oral sodium iodide 131
I. However, administration of the therapeutic unsealed by-product dosage specified in the written directive may be delegated if the individuals performing the administration are properly instructed in the written directive procedures and supervised accordingly.
Radioisotope Safety Exam (RISE) FAQs
What is the nature of the exam?
This is a computer-based examination. Candidates may review the Core Practice Exam
to help them understand the types of items that will be included on the exam.
How do I register for the RISE exam?
Registration for the RISE exam is open from December 2 to February 15. Please check back here on December 1, 2020, for the 2021 exam application.
How long is the exam?
Exam details, including the number of questions and exam length, are located here
What material does the exam cover?
Questions on radiopharmaceuticals, including clinically relevant beta emitters, PET radioisotopes, and radioiodines should be anticipated. Considerable content regarding radionuclides/radiopharmaceuticals will be included, and the exam will include all NRC-related issues.
Does the ABR provide guidelines to facilitate preparation?
The NRC website provides the general areas of training content under 10 CFR 35.290, 35.392, and 35.394, which are pertinent to the exam. The NRC website also provides rules and regulations applicable to the safe use of radiopharmaceuticals and compliance issues that are included on the exam. In addition, a study guide for the exam is available here
on the ABR website. Candidates may also review the Core Exam Study Guide
If I choose to defer taking the exam, what options/dates will be available to me later?
The separate RISE is given annually in the spring. Registration information is available on this website each year beginning December 1. Candidates are eligible to take the RISE up to seven years from the date their completed Forms A and B were submitted to the ABR.
What is the fee to take the exam?
The exam fee is located here
on this website.
Where can I take the exam?
The separate RISE is administered remotely.
What benefit/rights does AU eligibility give me?
Being AU-eligible through the ABR gives the potential to bypass some of the requirements set forth by the NRC to become an Authorized User. However, the ABR suggests candidates contact their institution/workplace for information regarding its particular nuclear radiology requirements.
When will I receive my exam results?
Results for the separate RISE will be posted on myABR approximately three weeks after candidates take the exam.